News + Filings Holdings
|
VANGUARD GROUP INC
> NTLA
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Intellia Therapeutics, Inc. | NTLA | 8,185,151 | 1,567,828 | 333,790,457,000 | 333,420,152,000 | $40,780.00 |
| 09/30/2022 | Intellia Therapeutics, Inc. | NTLA | 6,617,323 | 108,041 | 370,305,000 | 33,385,000 | $55.96 |
| 06/30/2022 | Intellia Therapeutics, Inc. | NTLA | 6,509,282 | 117,342 | 336,920,000 | -127,582,000 | $51.76 |
| 03/31/2022 | Intellia Therapeutics, Inc. | NTLA | 6,391,940 | -50,415 | 464,502,000 | -297,242,000 | $72.67 |
| 12/31/2021 | Intellia Therapeutics, Inc. | NTLA | 6,442,355 | 89,021 | 761,744,000 | -90,555,000 | $118.24 |
| 09/30/2021 | Intellia Therapeutics, Inc. | NTLA | 6,353,334 | 327,157 | 852,299,000 | -123,399,000 | $134.15 |
| 06/30/2021 | Intellia Therapeutics, Inc. | NTLA | 6,026,177 | 894,980 | 975,698,000 | 696,561,000 | $161.91 |
| 02/10/2021 | Intellia Therapeutics, Inc. | NTLA | 5,131,197 | 0 | 359,645,598 | 80,508,598 | $70.09 |
| 12/31/2020 | Intellia Therapeutics, Inc. | NTLA | 5,131,197 | 754,398 | 279,137,000 | 192,127,000 | $54.40 |
| 09/30/2020 | Intellia Therapeutics, Inc. | NTLA | 4,376,799 | 119,603 | 87,010,000 | -2,476,000 | $19.88 |
| 06/30/2020 | Intellia Therapeutics, Inc. | NTLA | 4,257,196 | 768,947 | 89,486,000 | 46,825,000 | $21.02 |
| 03/31/2020 | Intellia Therapeutics, Inc. | NTLA | 3,488,249 | -35,950 | 42,661,000 | -9,040,000 | $12.23 |
| 12/31/2019 | Intellia Therapeutics, Inc. | NTLA | 3,524,199 | 71,738 | 51,701,000 | 5,609,000 | $14.67 |
| 09/30/2019 | Intellia Therapeutics, Inc. | NTLA | 3,452,461 | 268,345 | 46,092,000 | -6,032,000 | $13.35 |
| 06/30/2019 | Intellia Therapeutics, Inc. | NTLA | 3,184,116 | 371,724 | 52,124,000 | 4,089,000 | $16.37 |
| 03/31/2019 | Intellia Therapeutics, Inc. | NTLA | 2,812,392 | 66,266 | 48,035,000 | 10,550,000 | $17.08 |
| 02/11/2019 | Intellia Therapeutics, Inc. | NTLA | 2,746,126 | 0 | 37,649,387 | 164,387 | $13.71 |
| 12/31/2018 | Intellia Therapeutics, Inc. | NTLA | 2,746,126 | 92,961 | 37,485,000 | -38,449,000 | $13.65 |
| 09/30/2018 | Intellia Therapeutics, Inc. | NTLA | 2,653,165 | 287,682 | 75,934,000 | 11,214,000 | $28.62 |
| 06/30/2018 | Intellia Therapeutics, Inc. | NTLA | 2,365,483 | 355,970 | 64,720,000 | 22,339,000 | $27.36 |
| 03/31/2018 | Intellia Therapeutics, Inc. | NTLA | 2,009,513 | 173,032 | 42,381,000 | 7,084,000 | $21.09 |
| 12/31/2017 | Intellia Therapeutics, Inc. | NTLA | 1,836,481 | 791,188 | 35,297,000 | 9,321,000 | $19.22 |
| 09/30/2017 | Intellia Therapeutics, Inc. | NTLA | 1,045,293 | 48,005 | 25,976,000 | 25,960,043 | $24.85 |
| 06/30/2017 | Intellia Therapeutics, Inc. | NTLA | 997,288 | 92,580 | 15,957 | -12,731,043 | $0.02 |
| 03/31/2017 | Intellia Therapeutics, Inc. | NTLA | 904,708 | 33,925 | 12,747,000 | 1,331,000 | $14.09 |
| 12/31/2016 | Intellia Therapeutics, Inc. | NTLA | 870,783 | 431,153 | 11,416,000 | 3,933,000 | $13.11 |
| 09/30/2016 | Intellia Therapeutics, Inc. | NTLA | 439,630 | 439,630 | 7,483,000 | 7,483,000 | $17.02 |
| 06/30/2016 | Intellia Therapeutics, Inc. | NTLA | 416,564 | 416,564 | 8,894,000 | 8,894,000 | $21.35 |
| << Prev Next >> |
|